The Ketamine Chorus: NYT Trumpets New Anti-Suicide Drug
The drumbeat for ketamine as a way to halt the rising suicide rate is upon us, as the New York Times has now joined the chorus. This is encouraging news unless of course you recall a couple of things: how recent enthusiasm from the medical-industrial complex for increased opioid use for pain resulted in the current opioid epidemic; and how the NYT has joined other notorious choruses such as Ahmed Chalabi’s one that sang about WMDs in Iraq. On November 30, 2018, the NYT published a lengthy op-ed “Can We Stop Suicides?” in which Moises Velasquez-Manoff offers this solution: “an old anesthetic called ketamine that, at low doses, can halt suicidal thoughts almost immediately.”